A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant Patients
NCT07641686 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-06-11
Summary
A total of 120 Chinese male subjects aged 18-50 years who have undergone hair transplantation are planned to be enrolled in this study. Among them, 90 participants with mild-to-moderate scalp seborrheic dermatitis (hereinafter abbreviated as SD) will be stratified and randomly allocated into two groups based on a randomization table with stratification factors including SD severity grading, alopecia classification and age. Subjects in the test product group (hereinafter referred to as the holistic group) will use the test shampoo plus basic shampoo, while those in the basic control group will receive only basic shampoo. The remaining 30 non-SD subjects will constitute the non-SD control group and use basic shampoo alone.
1. Primary Objective To compare pre- and post-treatment changes in clinical, physiological, biological and microecological parameters related to SD manifestations, scalp health and skin barrier repair (including transepidermal water loss, scalp hydration, scalp sebum content, etc.) between the holistic group receiving the investigational shampoo regimen and the basic control group via non-invasive instrumental measurement, clinical assessment, clinical photography and subject self-evaluation. The safety and efficacy of the test product in improving scalp condition and skin barrier function will be evaluated, and its potential underlying mechanisms will be explored.
2. Secondary Objective To investigate the impacts of the test product versus the control shampoo on hair transplant-associated complications (e.g., folliculitis), wound healing, follicular shedding phase, graft survival rate and hair growth parameters among SD patients.
3. Exploratory Objective To collect baseline clinical, physiological, biological and scalp microecological data from non-SD recipients after hair transplantation for reference purposes.
Conditions
- Hair Transplantation
- Seborrheic Dermatitis
- Scalp Care
Interventions
- OTHER
-
Intervention Name:Test shampoo + basic shampoo for scalp care
The whole intervention is split into three sequential research stages: the pretreatment stage, the first test stage and the long-term follow-up stage. 1.14 days before enrollment up to the day of enrollment: Test shampoo A is used 3 times every week. If participants habitually wash hair every day, they shall use test shampoo A for 3 fixed weekly washes, and use basic shampoo for all other remaining shampooing times. 2.From the 7th study day to the 28th study day: Test shampoo B is used 3 times every week. Daily shampooing users apply test shampoo B 3 times weekly, and basic shampoo for additional hair washing. 3.From the 28th study day to the 9th month of the trial: Test shampoo A is used once weekly plus basic shampoo twice weekly. For daily shampoo users, test shampoo A can be flexibly used 1 to 3 times per week, with basic shampoo used for leftover washing times.
- OTHER
-
Basic scalp care shampoo
Basic shampoo is adopted consistently during three research periods: pretreatment stage (14 days before enrollment to enrollment day), first test stage (7th study day to 28th study day), and follow-up stage (28th study day to the 9th trial month). The standard usage frequency is 3 times weekly; participants with daily hair-washing habit are permitted to use basic shampoo every single day.All participants must finish shampooing at home 12-36 hours prior to each study visit and keep the same pre-visit shampooing interval all through the trial.
Sponsors & Collaborators
-
ChinaNorm
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-21
- Primary Completion
- 2027-12-30
- Completion
- 2027-12-30
Countries
- China
Study Locations
More Related Trials
-
A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
NCT06916793 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
NCT04784533 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
NCT07076706 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Safety, Effectiveness and In-Use Tolerability of Hair Growth and Scalp Health Serum in Subjects With Mild to Moderate Hair Thinning.
NCT07195487 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
NCT00958750 ·Status: COMPLETED ·Phase: PHASE3
-
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
NCT05296863 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-Omics Insights Into Androgenetic Alopecia
NCT07603544 ·Status: RECRUITING
-
A Phase II Study in Patients With Alopecia Areata
NCT04346316 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study of KX-826 With Adult Male Patients With AGA
NCT06126965 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of the Benefits of Shampoo During 4 Weeks of Treatment and After 24 Weeks
NCT07292467 ·Status: COMPLETED
-
The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome
NCT06146166 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
NCT01231607 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata
NCT03137381 ·Status: COMPLETED ·Phase: PHASE2
-
Development and Standardization Methods
NCT06802237 ·Status: COMPLETED
-
Characterization and Risk Factors of Folliculitis After Hair Transplantation
NCT05793164 ·Status: COMPLETED
-
Minoxidil for Treating White Hair: A Randomized Controlled Trial
NCT06813963 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
NCT07012486 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)
NCT05135468 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia
NCT07370519 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation and Comparison of the Benefits of Routine vs Shampoo Alone During 4 Weeks Treatment and 12 Weeks Remanence
NCT07133334 ·Status: COMPLETED
-
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
NCT07080931 ·Status: RECRUITING ·Phase: PHASE3
-
Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
NCT02460289 ·Status: COMPLETED ·Phase: NA
-
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
NCT03898479 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata
NCT07617597 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
NCT05051761 ·Status: COMPLETED ·Phase: PHASE3